September 1, 2018EuroIntervention
First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation
Key result
Implantation of the Tricento transcatheter heart valve in a 74-year-old woman with severe tricuspid regurgitation reduced caval vein regurgitant volume and led to clinical improvement at 3 months.
Why the study?
Does the Tricento transcatheter heart valve improve symptoms and reduce regurgitant volume in patients with severe tricuspid regurgitation?
Population
1 74-year-old woman with severe tricuspid regurgitation and holosystolic hepatic vein backflow who is not a…
Design
Case_report
Follow-up
3 months
Authors
Discussion
Loading...
Member takes
Implication
First-in-human Tricento implantation shows short-term TR improvement; hypothesis-generating and requires prospective trials before adoption.
Study Design
Type
Case Report (n=1)
Structured PICO
Does the Tricento transcatheter heart valve improve symptoms and reduce regurgitant volume in patients with severe tricuspid regurgitation?
P
Population
A 74-year-old woman with severe tricuspid regurgitation and holosystolic hepatic vein backflow who underwent implantation of the Tricento transcatheter heart valve, followed for 3 months.
I
Intervention
Implantation of the bicavally anchored Tricento transcatheter heart valve via transvenous transfemoral access
O
Outcome
Caval vein regurgitant volume reduction and symptomatic/clinical improvement at three-month follow-upsurrogate
The first-in-man implantation of the Tricento transcatheter heart valve demonstrates procedural feasibility and early clinical improvement for severe tricuspid regurgitation.
Cite This Study
Toggweiler et al. (2018) conducted a case report in Severe tricuspid regurgitation (n=1). Tricento transcatheter heart valve was evaluated on Caval vein regurgitant volume and symptomatic/clinical improvement. Implantation of the Tricento transcatheter heart valve in a 74-year-old woman with severe tricuspid regurgitation reduced caval vein regurgitant volume and led to clinical improvement at 3 months.